This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Garber, K. Purchase of Aton spotlights HDAC inhibitors. Nat Biotechnol 22, 364–365 (2004). https://doi.org/10.1038/nbt0404-364
Issue Date:
DOI: https://doi.org/10.1038/nbt0404-364
This article is cited by
-
Novel histone deacetylase 8-selective inhibitor 1,3,4-oxadiazole-alanine hybrid induces apoptosis in breast cancer cells
Apoptosis (2017)
-
An efficient anticancer histone deacetylase inhibitor and its analogues for human HDAC8
Medicinal Chemistry Research (2012)
-
Epigenetic phenomena linked to diabetic complications
Nature Reviews Endocrinology (2010)
-
Identification of type-specific anticancer histone deacetylase inhibitors: road to success
Cancer Chemotherapy and Pharmacology (2010)
-
HDAC inhibitors overcome first hurdle
Nature Biotechnology (2007)